RESEARCHDIAGNOSTICSTRANSLATIONOUTREACH
 
Project Detail
MK8259-022: An open label, single group assignment design study to correlate soluble ST2 with clinical, endoscopic and histological activity in moderate to severe Ulcerative Colitis patients under golimumab (Evolution)
 
Team
Fátima Carneiro (PI), Helena Barroca, Rita Barros
 
Sponsor
Merck
 
Dates and Lifetime
From: 2015-02-05 To: 2020-12-31
Duration: 71 months
 
Reference
MK8259-022
  
 
@ 2014 Ipatimup Institute of Molecular Pathology and Immunology of the University of Porto
A
A
A

Send Email
From
To
Subject